Najít nástroj

Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc is a leading biopharmaceutical company that specializes in the development of RNA interference (RNAi) therapeutics for the treatment of genetic and other diseases. The company's cutting-edge approach to drug development involves targeting specific genes and silencing them using RNAi technology. Alnylam's extensive pipeline includes potential treatments for a wide range of diseases, including rare genetic disorders, cardiovascular disease, and cancer. The company is dedicated to research and development, with a team of world-class scientists committed to discovering new therapies and advancing the field of RNAi. Headquartered in Cambridge, Massachusetts, Alnylam has a global presence with operations in Europe and Asia. The company is deeply committed to improving the lives of patients through the development of innovative and effective treatments.Instrument specification in OANDA
Začněte obchodovat hned s rychlým otevřením účtu.
Zaregistrujte se a obchodujte na nejaktivnějších trzích
OTEVŘÍT ÚČET